Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOXAF: Moxonidine for AF Recurrence After PVI
NCT01791699Phase 4Completed
- Start
- Aug 2012
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of moxonidine in Atrial fibrillation (AFib). Started Aug 2012; status: completed.
02
Drugs
moxonidine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT01791699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01791699.